Pacific Software Inc. Secures Strategic License Agreement with the University of California for Innovative Technology for Stimulating Collagen Production
As part of the agreement, UC Regents will become an equity partner in Pacific.
- As part of the agreement, UC Regents will become an equity partner in Pacific.
- The particular peptide IDE inhibitors covered by this licensing agreement were specifically tailored for dermatological applications.
- Though more widely known for its role in regulating blood sugar, insulin also directly stimulates collagen production within skin cells.
- For more information about Pacific and our exciting new venture with the Regents of the University of California, please visit www.dreamaderm.com .